ATC Group: A04AD01 Scopolamine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A04AD01 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A04 Antiemetics and antinauseants
3 A04A Antiemetics and antinauseants
4 A04AD Other antiemetics
5 A04AD01 Scopolamine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
T-DERMAL - Transdermal 1.5 mg

Active ingredients in A04AD01

Active Ingredient Description

Scopolamine is a naturally occurring belladonna alkaloid and has anticholinergic properties. It acts as a competitive antagonist to acetylchloline and other parasympathomimetic agents. Its mechanism of action in the central nervous system in preventing motion sickness has yet to be elucidated. Scopolamine produces classical symptoms of parasympathetic blockade.

Related product monographs

Title Information Source Document Type  
KWELLS KIDS Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SCOPODERM Transdermal patch Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Malta (MT)

Netherlands (NL)

New Zealand (NZ)

Singapore (SG)

South Africa (ZA)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.